Trial Profile
The Effect of Saxagliptin on Glucose Fluctuation and Immune Regulation in Patients With Type 1 Diabetes
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Saxagliptin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 05 Jul 2016 Planned End Date changed from 1 Jul 2016 to 1 Mar 2017.
- 05 Jul 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Mar 2017.
- 25 Jan 2015 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov record.